Contact

All Stories

  1. An integrated machine learning and computational framework with experimental validation for the identification of novel CXCR4 inhibitors

    Article • European Journal of Medicinal Chemistry, September 2026, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  2. Targeting tryparedoxin-dependent peroxidase (TXNPx) enzyme to identify repurposing drug candidates from FDA-approved drugs and natural products using virtual screening, ADME/Tox and MD simulations

    Article • Biochemistry and Biophysics Reports, September 2025, Elsevier

    Mr Mohammad Yousuf Ansari, Dr. MUSHTAQ AHMAD WANI

  3. Integrating in silico and in vitro approaches for identifying potential TNF-α inhibitors

    Article • International Journal of Biological Macromolecules, September 2025, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  4. Machine learning framework coupled with CADD for predicting sphingosine kinase 1 inhibitors

    Article • Computers in Biology and Medicine, August 2025, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  5. Computer-aided drug design approaches for the identification of potent inhibitors targeting elongation factor G of Mycobacterium tuberculosis

    Article • Journal of Molecular Graphics and Modelling, May 2025, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  6. Drugs repurposed against morphine and heroin dependence: molecular docking, DFT, MM-GBSA-based MD simulation studies

    Article • In Silico Pharmacology, April 2025, Springer Science + Business Media

    Dr. MUSHTAQ AHMAD WANI

  7. Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer's disease

    Article • European Journal of Medicinal Chemistry, February 2025, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  8. Predictive Modeling and Drug Repurposing for Type-II Diabetes

    Article • ACS Medicinal Chemistry Letters, October 2024, American Chemical Society (ACS)

    Dr. MUSHTAQ AHMAD WANI

  9. Unlocking translational machinery for antitubercular drug development

    Article • Trends in Biochemical Sciences, March 2024, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  10. An update on ATP synthase inhibitors: A unique target for drug development in M. tuberculosis

    Article • Progress in Biophysics and Molecular Biology, April 2023, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  11. Targeting the cytochrome bc1 complex for drug development in M. tuberculosis: review

    Article • Molecular Diversity, November 2021, Springer Science + Business Media

    Dr. MUSHTAQ AHMAD WANI

  12. Machine learning-enabled predictive modeling to precisely identify the antimicrobial peptides

    Article • Medical & Biological Engineering & Computing, October 2021, Springer Science + Business Media

    Dr. MUSHTAQ AHMAD WANI

  13. Development and validation of consensus machine learning-based models for the prediction of novel small molecules as potential anti-tubercular agents

    Article • Molecular Diversity, June 2021, Springer Science + Business Media

    Dr. MUSHTAQ AHMAD WANI

  14. Denouement of Chemicals on Amyotrophic Lateral Sclerosis: Is Green Chemistry the Answer

    Article • Medicinal Chemistry, November 2020, Bentham Science Publishers

    Dr. MUSHTAQ AHMAD WANI

  15. Effect of environmental toxicants on neuronal functions

    Article • Environmental Science and Pollution Research, September 2020, Springer Science + Business Media

    Dr. MUSHTAQ AHMAD WANI

  16. Novel Pyrimidinone Derivatives Show Anticancer Activity and Induce Apoptosis: Synthesis, SAR and Putative Binding Mode

    Article • ChemistrySelect, April 2020, Wiley

    Dr. MUSHTAQ AHMAD WANI

  17. Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discovery

    Article • Expert Opinion on Drug Discovery, November 2019, Taylor & Francis

    Dr. MUSHTAQ AHMAD WANI

  18. Klf5 regulates lineage formation in the pre-implantation mouse embryo

    Article • Development, December 2010, The Company of Biologists

    Dr. MUSHTAQ AHMAD WANI

  19. Kruppel-like factor 2 regulates thymocyte and T-cell migration

    Article • Nature, July 2006, Springer Science + Business Media

    Dr. MUSHTAQ AHMAD WANI

  20. KLF2 is essential for primitive erythropoiesis and regulates the human and murine embryonic β-like globin genes in vivo

    Article • Blood, October 2005, American Society of Hematology

    Dr. MUSHTAQ AHMAD WANI

  21. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis

    Article • Journal of Molecular and Cellular Cardiology, November 2004, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  22. Differentiation of Bone Marrow Stromal Cells Into the Cardiac Phenotype Requires Intercellular Communication With Myocytes

    Article • Circulation, October 2004, Wolters Kluwer Health

    Dr. MUSHTAQ AHMAD WANI

  23. The α2 Isoform of Na,K-ATPase Mediates Ouabain-induced Cardiac Inotropy in Mice

    Article • Journal of Biological Chemistry, December 2003, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  24. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart

    Article • Journal of Molecular and Cellular Cardiology, September 2003, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  25. TRAF2 Exerts Its Antiapoptotic Effect by Regulating the Expression of Krüppel-Like Factor LKLF

    Article • Molecular and Cellular Biology, August 2003, ASM Journals

    Dr. MUSHTAQ AHMAD WANI

  26. Lung Krüppel-like Factor Contains an Autoinhibitory Domain That Regulates Its Transcriptional Activation by Binding WWP1, an E3 Ubiquitin Ligase

    Article • Journal of Biological Chemistry, August 2001, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  27. AnkB, a Periplasmic Ankyrin-Like Protein inPseudomonas aeruginosa, Is Required for Optimal Catalase B (KatB) Activity and Resistance to Hydrogen Peroxide

    Article • Journal of Bacteriology, August 2000, ASM Journals

    Dr. MUSHTAQ AHMAD WANI

  28. cDNA Isolation, Genomic Structure, Regulation, and Chromosomal Localization of Human Lung Kruppel-like Factor

    Article • Genomics, August 1999, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  29. Lung Kruppel-like Factor, a Zinc Finger Transcription Factor, Is Essential for Normal Lung Development

    Article • Journal of Biological Chemistry, July 1999, Elsevier

    Dr. MUSHTAQ AHMAD WANI

  30. Influence of p53 tumor suppressor protein on bias of DNA repair and apoptotic response in human cells

    Article • Carcinogenesis, May 1999, Oxford University Press (OUP)

    Dr. MUSHTAQ AHMAD WANI

  31. A gene encoding an intestinal-enriched member of the Kruppel-like factor family expressed in intestinal epithelial cells

    Article • Nucleic Acids Research, March 1999, Oxford University Press (OUP)

    Dr. MUSHTAQ AHMAD WANI

  32. Loss of LKLF Function Results in Embryonic Lethality in Mice

    Article • Transgenic Research, July 1998, Springer Science + Business Media

    Dr. MUSHTAQ AHMAD WANI

  33. Expression ofRap 1 suppresses genomic instability ofH-ras transformed mouse fibroblasts

    Article • Somatic Cell and Molecular Genetics, March 1997, Springer Science + Business Media

    Dr. MUSHTAQ AHMAD WANI

  34. Mitotic and post mitotic consequences of genomic instability induced by oncogenic Ha-Ras

    Article • Somatic Cell and Molecular Genetics, July 1995, Springer Science + Business Media

    Dr. MUSHTAQ AHMAD WANI

  35. Identification and partial sequence of a cDNA that is differentially expressed in human brain tumors

    Article • Cancer Letters, March 1995, Elsevier

    Dr Ronald E Warnick, Dr. MUSHTAQ AHMAD WANI

  36. Therapeutic efficacy of camptothecin derivatives against human malignant melanoma xenografts

    Article • Melanoma Research, February 1994, Wolters Kluwer Health

    Dr. MUSHTAQ AHMAD WANI